| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.71▲ | 1.72▲ | 1.72▲ | 1.68▲ | 1.58▲ |
| MA10 | 1.71▲ | 1.72▼ | 1.69▲ | 1.64▲ | 1.58▲ |
| MA20 | 1.72▲ | 1.69▲ | 1.67▲ | 1.57▲ | 1.95▼ |
| MA50 | 1.72▼ | 1.67▲ | 1.66▲ | 1.64▲ | 2.03▼ |
| MA100 | 1.69▲ | 1.65▲ | 1.63▲ | 1.95▼ | 3.42▼ |
| MA200 | 1.67▲ | 1.62▲ | 1.51▲ | 1.87▼ | 3.15▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | 0.002▲ | 0.008▲ | 0.025▲ | -0.009▼ |
| RSI | 54.906▲ | 57.930▲ | 57.792▲ | 56.853▲ | 45.820▼ |
| STOCH | 51.667 | 46.051 | 81.075▲ | 71.136 | 27.355 |
| WILL %R | -28.571 | -22.222▲ | -17.647▲ | -22.857▲ | -68.056 |
| CCI | 55.396 | 0.871 | 57.908 | 97.119 | -28.411 |
|
Wednesday, October 15, 2025 01:19 PM
Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies and candidates, today ...
|
|
Tuesday, September 16, 2025 05:04 AM
LONDON and GAITHERSBURG, Md., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/10/25 | 1.66 | 1.755 | 1.66 | 1.72 | 2,481,536 |
| 14/10/25 | 1.59 | 1.65 | 1.58 | 1.62 | 2,167,920 |
| 13/10/25 | 1.68 | 1.73 | 1.635 | 1.65 | 2,755,254 |
| 10/10/25 | 1.77 | 1.79 | 1.62 | 1.66 | 2,809,405 |
| 09/10/25 | 1.7688 | 1.80 | 1.72 | 1.76 | 3,866,650 |
| 08/10/25 | 1.50 | 1.775 | 1.50 | 1.76 | 7,673,061 |
| 07/10/25 | 1.565 | 1.57 | 1.45 | 1.49 | 4,328,446 |
| 06/10/25 | 1.61 | 1.65 | 1.53 | 1.56 | 2,735,407 |
| 03/10/25 | 1.61 | 1.64 | 1.57 | 1.61 | 2,334,451 |
| 02/10/25 | 1.69 | 1.6994 | 1.56 | 1.61 | 2,805,750 |
|
|
||||
|
|
||||
|
|